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In HIT-T15 cells grown in the absence of glucose, Northern blot analysis of total RNA revealed a major 
0.5 kb preproinsulin (pp1) mRNA transcript which co-migrated with the mature transcript from a human 
insulinoma. In 4 h tissue cultures, glucose (2-20 mM) stimulated HIT cell pp1 mRNA levels in a markedly 
dose-dependent manner. Glucose-stimulated pp1 mRNA was (i) inhibited by actinomycin D, suggesting that 
regulation may be in part transcriptional, and (ii) potentiated by agents known to activate B cell protein 
kinases. HIT cells represent a unique model for investigating long term regulation of insulin gene expression 
and biosynthesis. 
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1. INTRODUCTION 
In pancreatic B cells, a major physiological 
regulator of both insulin biosynthesis and secretion 
is extracellular glucose. The events whereby 
glucose stimulates insulin release are beginning to 
be understood at a molecular level. In contrast, 
although the stimulatory effects of glucose on in- 
sulin biosynthesis are well established [1,2], the 
molecular mechanisms remain unclear. With the 
development of preproinsulin cDNA sequences, it 
is now feasible to study transcriptional regulation 
of insulin gene expression by glucose. 
The clonal insulin-secreting B cell line HIT-T15 
was derived from Syrian hamster islets by SV40 
transformation [3] and has been extensively 
characterised in our laboratory [4]. In contrast to 
other B cell lines [5], HIT cells retain the essential 
insulin secretory characteristics of the normal dif- 
ferentiated B cell, including responsiveness to 
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glucose [4,6]. In the Syrian hamster, as in humans 
[7], there is a single preproinsulin gene, whereas 
rats and mice possess two non-allelic genes [8]. 
Moreover, there is evidence that the two rat 
preproinsulin genes may be differentially regulated 
under stimulatory conditions [9]. Therefore, HIT 
cells potentially represent a more appropriate 
model for defining the molecular events regulating 
insulin biosynthesis. In the present study we have 
evaluated this potential and demonstrate regula- 
tion of HIT cell preproinsulin (pp1) mRNA levels 
by glucose, possibly at the level of transcription. 
Moreover there is evidence implicating protein 
kinases as putative mediators of glucose 
regulation. 
2. EXPERIMENTAL 
2.1. Materials 
Tissue culture medium RPM1 1640 and foetal 
calf serum were purchased from Gibco (Paisley, 
Scotland). [32P]dATP (spec. act. > 3000 Ci/mmol) 
and the CAMP radioimmunoassay kit was pur- 
chased from Amersham (Bucks, England). The 
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phorbol ester 12-0-tetradecanoylphorbol 13- 
acetate (TPA) was purchased from PL Biochemi- 
cals (North~pton, England). Forskolin was pur- 
chased from Calbiochem (Cambridge, England). 
X-ray film was purchased from Kodak (Liverpool, 
Merseyside, England). All other reagents were pur- 
chased from BDH or Sigma (Poole, Dorset, 
England). 
Emeryville, CA, USA, and was labelled with 
[32P]dATP by random hexanucleotide priming 
[lo]. Total RNA was electrophoresed on 
agarose/form~dehyde gels (111, blotted to 
nitrocellulose filters and hybridized as described 
WI. 
3. RESULTS AND DISCUSSION 
HIT cells (clone T15) were grown at 37°C in 
RPM1 1640 supplemented with glucose (11 mM) 
antibiotics and 10% (v/v) foetal calf serum as 
described (41. In all experiments, HIT cells were 
preincubated for 1 h in culture medium without 
glucose. Subsequently, insulin release and ppf 
mRNA were assayed following incubation for 4 h 
in culture medium supplemented with glucose and 
additions as listed in section 3. Insulin release was 
measured by radioimmunoassay [4]. Intracellular 
CAMP was assayed by ra~oi~unoassay using a 
commercial kit. pp1 mRNA was assayed by 
Northern blotting followed by autoradiography 
and densitometry. Autoradiographic exposures 
were shown to be in the linear resolution range of 
the film (Kodak X-AR). The probe, a Syrian 
hamster cDNA (p Shins l/HBlOl) fg] was a gift 
from Dr G.I. Bell, Chiron Corporation, 
Previous studies using rat of mouse islets of 
Langerhans or rat cell lines suggest that glucose 
regulation of insulin biosynthesis may be mediated 
through changes in the rates of both insulin gene 
transcription and translation of mature transcript. 
Translational regulation is rapid, occurring within 
minutes 113-151, and operates by (i) stimulating 
initiation of pp1 synthesis; (ii) increasing the 
elongation rate of nascent pp1; (iii) stimulating 
transfer of initiated pp1 mRNA transcript from the 
cytoplasm to microsomal membranes [ 161. In con- 
trast, long term regulation, occurring over hours to 
days, may be transcriptional and previous studies 
[14,17-193 have suggested that glucose may 
regulate insulin gene expression by modulating pp1 
mRNA levels. 
A 
Northern blot analysis of HIT cell RNA from 
cells grown without glucose revealed a 0.5 kb ppI 
transcript which co-migrated with mature 
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Fig.1. Effect of glucose on HIT cell insulin release and pp1 mRNA. (A) HIT cell insulin release measured by 
radioimmunoassay after 4 h culture in RPM1 in the absence or presence of glucose (2-20 mM). Data are presented as 
mean f 95% confidence limits (n = 3). The dependence of insulin release on glucose concentration was significant by 
anovar (JJ < 0.001). (B) Dose-dependent stimulation of HIT cell pp1 mRNA by glucose after 4 h culture. Data, 
determined by densitometry of Northern blots, are representative of duphcate experiments. 
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transcript produced by a primary human in- 
sulinoma. Incubation for 4 h in the presence of 
glucose (2-20 mM) stimulated accumulation of 
HIT cell pp1 mRNA relative to controls incubated 
in the absence of glucose (fig.lB). Moreover, pp1 
mRNA accumulation was markedly dose- 
dependent with respect to glucose concentration: 
raising medium glucose induced progressive in- 
crements in pp1 mRNA with an overall 4-fold 
stimulation between 2 and 20 mM glucose. 
Similarly, isolated rat islets incubated for 4 h in 
high glucose (28 mM) demonstrated a 5-fold eleva- 
tion of pp1 mRNA relative to low glucose 
(2.8 mM), although pp1 mRNA was considerably 
reduced compared to non-incubated islets [19]. 
Moreover, in the same study the authors report 
both a 45% reduction in the translatable activity of 
islet mRNA from incubated islets and impaired 
proinsulin biosynthesis at low glucose. These 
findings are consistent with further observations 
that freshly isolated islets demonstrate acute rapid 
losses of pp1 mRNA concomitant with reduced 
rates of proinsulin biosynthesis and require a 
recovery period in culture of up to 24 h [17,20]. 
This may explain in part why glucose-stimulated 
pp1 mRNA accumulation was more dose- 
dependent in HIT cells than in 24 h cultured rat 
islets [21]. 
Although glucose regulates insulin biosynthesis 
and secretion, both processes may also function in- 
dependently [2]: we also demonstrate dissociation 
between pp1 mRNA content and insulin secretion 
with respect to both induction by glucose and 
modulation of glucose stimulation. Thus, like in- 
sulin biosynthesis [22], glucose-stimulated pp1 
mRNA accumulation showed a lower threshold 
compared with insulin release (fig.1). In contrast, 
pp1 mRNA accumulation was further stimulated 
on raising medium glucose to 20 mM whereas in- 
sulin release, like biosynthesis [22], was saturated 
at 10 mM glucose (fig.1). The observation that in- 
sulin biosynthesis persists after glucose stimulation 
has ceased [2] may be related to this continued ac- 
cumulation of pp1 mRNA during periods of 
hyperglycaemic stress. In addition, dissociation 
between glucose-stimulated parameters was also 
evident in that whereas theophylline and bombesin 
potentiated HIT cell insulin release (fig.3), pp1 
mRNA levels remained unchanged (fig.4). 
It has been suggested [20,21] that long term 
regulation of insulin gene expression by glucose oc- 
curs through simultaneous stimulation of 
transcription and inhibition of pp1 mRNA 
degradation. Incubation of HIT cells for 4 h with 
the RNA polymerase inhibitor actinomycin D 
(1 pg/ml) reduced by over 50% the stimulatory ef- 
fect of 10 mM glucose on pp1 mRNA but had no 
effect on basal levels (fig.2). This suggests that 
glucose-stimulated HIT cell pp1 mRNA accumula- 
tion may also be comprised of transcriptional or 
transcript-stabilising components. The latter 
possibility cannot be ruled out since actinomycin D 
is known to affect other cellular processes, in- 
cluding initiation of protein synthesis [23], and 
may therefore indirectly affect transcript stability. 
However, the observation that actinomycin D did 
not affect basal or glucose-stimulated insulin 
secretory rates implies that inhibition of glucose- 
stimulated pp1 mRNA is not simply attributable to 
impairment of HIT cell viability. Resolution of 
this point awaits the development of a sensitive 
assay for pp1 mRNA-specific transcription: the 
Fig.2. Effects of actinomycin D on glucose-stimulated 
HIT cell pp1 mRNA and insulin release. After 4 h 
incubation in RPM1 supplemented as shown, insulin 
release was measured by radioimmunoassay, ppI mRNA 
by Northern blotting followed by autoradiography and 
densitometry. Data presented are representative of 
duplicate experiments. 
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Fig.3. Modulation of glucose-stimulated insulin release. HIT cells were incubated for 4 h with the additions shown. 
Insulin release, measured by radioimmunoassay, is expressed as  percentage of the mean rate observed with 10 mM 
glucose. Data are given as mean k SE (n = 3). The mean absolute rate of insulin release in controls (10 mM) was 1.7 + 
0.26 mu/lo6 cells. Significance (Student’s t-test) of the differences between test and control (10 mM glucose) are: 
*** P < 0.001. 
method employed in the above study [21] is inade- 
quate in that it fails to distinguish between mature 
and therefore translatable pp1 mRNA and the 
multiple precursor messengers characteristic of pp1 
genes [24]. 
Regulation of transcriptional activity by CAMP 
is well established in prokaryotes and has also been 
implicated in the control of several eukaryotic 
genes. The observation that addition of dibutyryl 
CAMP to isolated rat islets could partially mimic 
the stimulatory effect of glucose on pp1 mRNA 
[21] suggests that regulation of insulin gene expres- 
sion by glucose may also be mediated via CAMP. 
Moreover, in 7 day cultures of mouse islets, pp1 
mRNA was augmented to the same degree as 
glucose by leucine and ketoisocaproate, com- 
pounds which also increase CAMP [25]. In the pre- 
sent study, raising medium glucose to 10 mM 
induced a significant (P < 0.01, Student’s t-test) in- 
crement in HIT cell CAMP (6.4 + 0.5 to 9.8 -t 
0.6 pmol cAMP/106 cells (n = 4)) concomitant 
with a 2-fold stimulation of pp1 mRNA (fig.lB). 
In addition, incubation with the adenyl cyclase ac- 
tivator forskolin provoked marked potentiation of 
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the effects of glucose on both CAMP (26.1 f 
4.7 pmol cAMP/106 cells (n = 4)) and pp1 mRNA 
(2-fold, fig.4). These findings are consistent with a 
second messenger role for the CAMP system in the 
regulation of insulin gene expression. In contrast, 
the phosphodiesterase inhibitor theophylline failed 
to potentiate glucose-stimulated pp1 mRNA (fig.4) 
despite augmenting HIT cell CAMP to a level 
similar to that induced by forskolin (28.3 f 
3.3 pmol cAMP/106 cells (n = 4)). However, the 
observed dissociation between CAMP and pp1 
mRNA with theophylline may be related to effects 
of theophylline additional to elevation of CAMP 
such as inhibition of poly(ADP-ribose) synthetase 
activity in nuclei [26]. 
CAMP-mediated regulation of insulin secretion 
occurs through activation of CAMP-dependent 
protein kinase [27,28]. Similarly, CAMP-depen- 
dent phosphorylation may be instrumental in the 
regulation of pp1 mRNA levels, possible substrates 
including DNA-binding transcriptional factors and 
proteins regulating post-transcriptional processing 
or turnover of the mature transcript. In addition, 
fig.4 demonstrates 2-fold potentiation of glucose- 
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Fig.4. Modulation of glucose-stimulated ppI mRNA accumulation. Autoradiographs demonstrating Northern bIot 
analysis of HIT cell ppl mRNA are shown for 2 separate xperiments. Densitometry eveaIed Zfold potentiation of 
glucose-stimulated pp1 mRNA by both forskolin (A4) and TPA (B2). Theophylline (AZ) and bombesin (A3) proved 
ineffective. A positive control is provided by a primary human insulinoma (AS) producing mature insulin gene 
transcript. Autoradiographs are representative of duplicate blots. 
stimulated HIT cell ppI mRNA accumulation 
evoked by a phorbol ester known to activate Ca*+- 
phospholipid-dependent protein kinase (C kinase) 
in B cells [29]. In contrast, bombesin which in- 
duces phosphatidylinositol turnover [30] and 
therefore presumably activates C kinase via 
diacylglycerol, did not affect ppI mRNA content 
(fig.4). The role of protein kinase activity in the 
regulation of insulin gene expression clearly war- 
rants further investigation. 
We conclude from these studies that glucose 
regulates pp1 mRNA levels in HIT cells and that 
the mechanism of action of glucose may be 
mediated in part through protein kinases. HIT 
cells represent a unique model system for in- 
vestigating long-term regulation of insulin gene ex- 
pression and biosynthesis. 
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